NOVARTIS AG ADR (NYSE: NVS)

NOVARTIS AG ADR

NYSE: NVS (Novartis AG)

Last update: 4 days ago, 5:16PM

112.57

1.17 (1.05%)

Add to watchlist

Previous Close	111.40
Open	111.64
Volume	2,452,514
Avg. Volume (3M)	2,167,293
Market Cap	222,335,893,504

Price / Earnings (TTM)	19.18
Price / Earnings (Forward)	13.35
Price / Sales	4.29
Price / Book	4.89

52 Weeks Range	92.35 (-17%) — 120.92 (7%)
Earnings Date	29 Apr 2025
TTM Dividend Yield	3.54%

Market Trend

		Short Term	Medium Term
Industry	Drug Manufacturers - General (US)	Bullish	Bullish
	Drug Manufacturers - General (Global)	Bullish	Bullish
Stock	Novartis AG	Mixed	Bullish

AIStockmoo Score

1.9

Analyst Consensus	2.0
Insider Activity	NA
Price Volatility	2.0
Technical Moving Averages	1.5
Technical Oscillators	2.0
Average	1.88

Similar Stocks

Stock	Market Cap	DY	P/E (TTM)	P/B
NVS	222 B	3.54%	19.18	4.89
MRK	225 B	3.50%	13.24	4.78
LLY	723 B	0.67%	68.94	52.04
NVO	342 B	1.88%	23.22	16.26
JNJ	374 B	3.20%	26.81	5.50
ABBV	367 B	3.03%	87.24	109.22

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
Sector	Healthcare
Industry	Drug Manufacturers - General
Investment Style	Large Core
% Held by Institutions	6.76%

No data within this time range.

Date	Type	Details
20 Mar 2025	Announcement	Novartis receives third FDA approval for oral Fabhalta® (iptacopan) - the first and only treatment approved in C3 glomerulopathy (C3G)
28 Feb 2025	Announcement	Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)

TTM Dividend Yield	3.54%
5Y Average Dividend Yield	2.81%
Payout Ratio	63.71%

Ex Date	Announcement Date	Payment Date	Details
12 Mar 2025	20 Feb 2025	-	3.869541 Cash
09 Mar 2023	02 Feb 2023	20 Mar 2023	3.4693612 Cash
08 Mar 2022	03 Feb 2022	17 Mar 2022	3.3252497 Cash
04 Mar 2021	26 Jan 2021	15 Mar 2021	3.1990725 Cash
03 Mar 2020	31 Jan 2020	12 Mar 2020	3.0873655 Cash
04 Mar 2019	31 Jan 2019	13 Mar 2019	2.834128 Cash
06 Mar 2018	07 Mar 2018	25 Apr 2018	2.936451 Cash
01 Mar 2017	-	20 Apr 2017	2.717759 Cash
24 Feb 2016	-	15 Apr 2016	2.717946 Cash
02 Mar 2015	-	20 Apr 2015	2.665947 Cash
27 Feb 2014	-	10 Apr 2014	2.759789 Cash
26 Feb 2013	-	05 Apr 2013	2.42647 Cash
27 Feb 2012	-	05 Apr 2012	2.482145 Cash
24 Feb 2011	-	08 Apr 2011	2.36336 Cash
02 Mar 2010	-	13 Apr 2010	1.948359 Cash
24 Feb 2009	-	06 Apr 2009	1.714383 Cash
26 Feb 2008	-	11 Apr 2008	1.537471 Cash
06 Mar 2007	-	10 Apr 2007	1.096517 Cash
28 Feb 2006	-	03 Apr 2006	0.880052 Cash
01 Mar 2005	-	06 Apr 2005	0.88322 Cash
24 Feb 2004	-	30 Mar 2004	0.78117 Cash
04 Mar 2003	-	07 Apr 2003	0.70553 Cash
21 Mar 2002	-	22 Apr 2002	0.4557 Cash
22 Mar 2001	-	20 Apr 2001	0.4213 Cash
12 Apr 2000	-	11 May 2000	0.8195 Cash
21 Apr 1999	-	24 May 1999	0.8097 Cash
21 Apr 1998	-	19 May 1998	0.7109 Cash
16 Apr 1997	-	15 May 1997	0.5785 Cash
26 Feb 1997	-	19 Mar 1997	3.234 Cash
17 Apr 1996	-	16 May 1996	0.5156 Cash
01 May 1995	-	31 May 1995	0.418 Cash
Show more

Annual Dividend Yield

Year	Annual Dividend ($)	Frequency/Year	Yield %
2023	3.47	1	3.44
2022	3.33	1	3.67
2021	3.20	1	3.66
2020	3.09	1	3.27
2019	2.83	1	2.99
2018	2.94	1	3.82
2017	2.72	1	3.61
2016	2.72	1	4.16
2015	2.67	1	3.46
2014	2.76	1	3.32
2013	2.43	1	3.37
2012	2.48	1	4.38
2011	2.36	1	4.61
2010	1.95	1	3.69
2009	1.71	1	3.52
2008	1.54	1	3.45
2007	1.10	1	2.25
2006	0.880	1	1.71
2005	0.883	1	1.88
2004	0.781	1	1.73
2003	0.706	1	1.72
2002	0.456	1	1.39
2001	0.421	1	1.29
2000	0.820	1	2.04
1999	0.810	1	2.47
1998	0.711	1	1.62
1997	3.81	2	10.46
1996	0.516	1	2.00
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2025	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Profit Margin	23.09%
Operating Margin (TTM)	29.94%
Diluted EPS (TTM)	5.87
Quarterly Revenue Growth (YOY)	15.10%
Quarterly Earnings Growth (YOY)	-66.80%

Total Debt/Equity (MRQ)	71.16%
Current Ratio (MRQ)	1.03
Operating Cash Flow (TTM)	17.62 B
Levered Free Cash Flow (TTM)	12.04 B

Return on Assets (TTM)	10.09%
Return on Equity (TTM)	26.27%

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)